1000-7431
2011 Issue 4
..............page:378
Correlation between cervical intraepithelial neoplasia and papillomavirus genotypes
XU Xue1;ZHANG Jie2;WU Jing-bo2;HAN Fei31.Wannan Medical College;Wuhu 241001;China;2.Department of Pathology;Shanghai Fifth People’s Hospital;Shanghai 200240;China;3.Department of Pathology;Shanghai Chest Hospital;Shanghai 200030;China
XU Xue1;ZHANG Jie2;WU Jing-bo2;HAN Fei31.Wannan Medical College;Wuhu 241001;China;2.Department of Pathology;Shanghai Fifth People’s Hospital;Shanghai 200240;China;3.Department of Pathology;Shanghai Chest Hospital;Shanghai 200030;China
..............page:364-368
Retrospective analysis of positive LEEP surgical margin and residual lesion in 246 patients with cervical high grade squamous intraepithelial lesion and micro invasive cancer after LEEP conization
GAO Shu-jun;WANG Qing;ZHENG Rui-lian;CHEN Min;XIE Feng;DONG Jing;DIAO Wen-jing;SUI Long Medical Center of Diagnosis and Treatment for Cervical Diseases;Obstetrics and Gynecology Hospital of Fudan University;Shanghai 200011;China
GAO Shu-jun;WANG Qing;ZHENG Rui-lian;CHEN Min;XIE Feng;DONG Jing;DIAO Wen-jing;SUI Long Medical Center of Diagnosis and Treatment for Cervical Diseases;Obstetrics and Gynecology Hospital of Fudan University;Shanghai 200011;China
..............page:359-363
Association of DNA repair gene polymorphisms with response to platinum-based chemotherapy in patients with non-small cell lung cancer
LI Dai-rong1;YANG Yan-qing2;TIAN Ling1;WANG Li1;MA Hui-wen1;LI Qi-ying1;HUANG Xin-hua2 1.Department of Oncology;Chongqing Tumor Institute;Chongqing 400030;China;2.National Engineering Center for Biochip at Shanghai;Shanghai 201203;China
LI Dai-rong1;YANG Yan-qing2;TIAN Ling1;WANG Li1;MA Hui-wen1;LI Qi-ying1;HUANG Xin-hua2 1.Department of Oncology;Chongqing Tumor Institute;Chongqing 400030;China;2.National Engineering Center for Biochip at Shanghai;Shanghai 201203;China
..............page:348-353
Effect of tamoxifen in combination with 5’-Aza-2’-deoxycytidine on resistance to adriamycin in estrogen receptor-alpha-negative breast cancer cells induced by breast cancer resistance protein
WANG Lin1;2;ZHAO Lin1;REN Jie1;SONG Yi-ning1;FU Xiu-quan1;YAO Wei-fan1;JIN Wan-bao1;WEI Min-jie11.Department of Pharmacology;School of Pharmaceutical Science;China Medical University;Shenyang 110001;China;2.Department of Physiology;Harbin Medical University Daqing Branch;Daqing 163319;China
WANG Lin1;2;ZHAO Lin1;REN Jie1;SONG Yi-ning1;FU Xiu-quan1;YAO Wei-fan1;JIN Wan-bao1;WEI Min-jie11.Department of Pharmacology;School of Pharmaceutical Science;China Medical University;Shenyang 110001;China;2.Department of Physiology;Harbin Medical University Daqing Branch;Daqing 163319;China
..............page:299-303
Research progress in association between the ubiquitin ligase Pirh2 and malignant tumors
QIU Yan-yan;DONG Lan-lan;ZHU Guo-guo;LIU Yong-juan;HE Xiao-hua;LIU Wan-hong School of Medicine;Wuhan University;Wuhan 430071;China
QIU Yan-yan;DONG Lan-lan;ZHU Guo-guo;LIU Yong-juan;HE Xiao-hua;LIU Wan-hong School of Medicine;Wuhan University;Wuhan 430071;China
..............page:369-373
Safety of sequential exemestane therapy after 2-3 years’ tamoxifen treatment in postmenopausal women with hormone sensitive breast cancer
ZHOU Li-heng;LIU Guang-yu;DI Gen-hong;LU Jin-song;SHEN Zhen-zhou;SHAO Zhi-min Department of Breast Surgery;Cancer Hospital;Department of Oncology;Shanghai Medical School;Fudan University;Shanghai 200032;China
ZHOU Li-heng;LIU Guang-yu;DI Gen-hong;LU Jin-song;SHEN Zhen-zhou;SHAO Zhi-min Department of Breast Surgery;Cancer Hospital;Department of Oncology;Shanghai Medical School;Fudan University;Shanghai 200032;China
..............page:354-358
Advances in the research of bevacizumab in treating some solid tumors
WANG Yu;FANG Ming-zhi Department of Oncology;Nanjing Hospital of Traditional Chinese Medicine;Nanjing 210001;China
WANG Yu;FANG Ming-zhi Department of Oncology;Nanjing Hospital of Traditional Chinese Medicine;Nanjing 210001;China
..............page:379-384
Effects of stable transfection with shRNA-Notch2 on the proliferation,cell cycle and apoptosis of U251 glioma cell line
HE Xin;JIAO Bao-hua;ZHENG Ke-bin;TIAN Wei;LIANG Chao-hui Department of Neurosurgery;Second Affiliated Hospital;Hebei Medical University;Shijiazhuang 050000;China
HE Xin;JIAO Bao-hua;ZHENG Ke-bin;TIAN Wei;LIANG Chao-hui Department of Neurosurgery;Second Affiliated Hospital;Hebei Medical University;Shijiazhuang 050000;China
..............page:310-314
Effects of Kanglaite Injection combined with oxaliplatin on the proliferation and apoptosis of SW480 cells
CHE Xiao-ling;LI Jin;HE Jing-dong;CAO Wei-ke;DENG Zhi-kui Department of Oncology;First Huaian Hospital Affiliated to Nanjing Medical College;Huaian223300;China
CHE Xiao-ling;LI Jin;HE Jing-dong;CAO Wei-ke;DENG Zhi-kui Department of Oncology;First Huaian Hospital Affiliated to Nanjing Medical College;Huaian223300;China
..............page:321-325
The plasticity of CD133 antigen expression in human colon cancer cell line SW620
YANG Zhi-li;WANG Zhi-gang;ZHENG Qi Department of Surgery;Sixth People’s Hospital Affiliated to Shanghai Jiaotong University;Shanghai 200233;China
YANG Zhi-li;WANG Zhi-gang;ZHENG Qi Department of Surgery;Sixth People’s Hospital Affiliated to Shanghai Jiaotong University;Shanghai 200233;China
..............page:326-331
The uptake of ~(99m)Tc methoxyisobutylisonitrile in human lung adenocarcinoma cells is associated with changes of cellular drug resistance induced by dichloroacetate
WANG Encheng;SUN Xiaoguang;LIU Jianjun;XU Lian;HUANG Gang Department of Nuclear Medicine;Renji Hospital;School of Medicine;Shanghai Jiaotong University;Shanghai 200127;China
WANG Encheng;SUN Xiaoguang;LIU Jianjun;XU Lian;HUANG Gang Department of Nuclear Medicine;Renji Hospital;School of Medicine;Shanghai Jiaotong University;Shanghai 200127;China
..............page:294-298
Clinical significance of serum nidogen-2 and carbohydrate antigen 125 in patients with ovarian serous cystadenocarcinoma
CHEN Yan1;JIN Ping1;ZHANG Hong-xiu1;YANG Lan-sheng2;FENG Ying21.Department of Obstetrics and Gynecology;2.Department of Pathology;First Hospital;Lanzhou University;Lanzhou 730000;China
CHEN Yan1;JIN Ping1;ZHANG Hong-xiu1;YANG Lan-sheng2;FENG Ying21.Department of Obstetrics and Gynecology;2.Department of Pathology;First Hospital;Lanzhou University;Lanzhou 730000;China
..............page:339-342
1,25-（OH）2D3 enhances the chemotherapeutic effect of doxorubicin on gastric carcinoma cells
HU Ping-ping1;FANG Dong2;CHEN Miao3;41.Department of Pathology;2.Department of Oncology;Second People’s Hospital of Zhenjiang;Zhenjiang 212002;China;3.Department of Pathology;First People’s Hospital of Zhenjiang;Zhenjiang 212002;China;4.Department of Pathology;School of Medical Science and Laboratory Medicine;Jiangsu University;Zhenjiang 212013;China
HU Ping-ping1;FANG Dong2;CHEN Miao3;41.Department of Pathology;2.Department of Oncology;Second People’s Hospital of Zhenjiang;Zhenjiang 212002;China;3.Department of Pathology;First People’s Hospital of Zhenjiang;Zhenjiang 212002;China;4.Department of Pathology;School of Medical Science and Laboratory Medicine;Jiangsu University;Zhenjiang 212013;China
..............page:304-309
A randomized clinical study of intensity-modulated radiotherapy vs conventional radiotherapy combined with chemotherapy in treating local/regional advanced nasopharyngeal carcinoma
LI Gui-sheng;CHEN Shao-jun;HUANG Hai-xin;NING Si-hai Department of Oncology;Fourth Affiliated Hospital of Guangxi Medical University;Liuzhou 545005;China
LI Gui-sheng;CHEN Shao-jun;HUANG Hai-xin;NING Si-hai Department of Oncology;Fourth Affiliated Hospital of Guangxi Medical University;Liuzhou 545005;China
..............page:343-347
The instruments of quality of life for patients with liver cancer and their applications
Liu Xiang-yan;Cao Wen-ting;Wang Yi-xin;Xu Yan Department of Nursing;Second Military Medical University;Shanghai 200433;China
Liu Xiang-yan;Cao Wen-ting;Wang Yi-xin;Xu Yan Department of Nursing;Second Military Medical University;Shanghai 200433;China
..............page:374-378
..............page:298
..............page:293
Correlation of TGF-β receptor type 1 gene Int7G24A and *6A polymorphisms with the risk of gastric cardia adenocarcinoma
GUO Wei;DONG Zhi-ming;GUO Yan-li;KUANG Gang;YANG Zhi-bin;SHAN Bao-en Hebei Cancer Institute;Fourth Hospital of Hebei Medical University;Shijiazhuang 050011;China
GUO Wei;DONG Zhi-ming;GUO Yan-li;KUANG Gang;YANG Zhi-bin;SHAN Bao-en Hebei Cancer Institute;Fourth Hospital of Hebei Medical University;Shijiazhuang 050011;China
..............page:332-338
Effects of deleted in liver cancer 1 gene transfection on the proliferation and migration of human ovarian cancer cell line OVCAR-3
SHI Hui-rong;ZHANG Hai-ling;WU Kai-yuan;LIU Hui-na Department of Gynecology and Obstetrics;First Affiliated Hospital of Zhengzhou University;Zhengzhou 450052;China
SHI Hui-rong;ZHANG Hai-ling;WU Kai-yuan;LIU Hui-na Department of Gynecology and Obstetrics;First Affiliated Hospital of Zhengzhou University;Zhengzhou 450052;China
..............page:315-320
Reversal of taxol resistance by cisplatin in human nasopharyngeal carcinoma cell lines
PENG Xiaowei1;2;LI Wei1;TAN Guolin11.Department of OtolaryngologyHead and Neck Surgery;Third Xiangya Hospital of Central South University;Changsha 410013;China;2.Department of Head and Neck Surgery;Tumor Hospital of Hunan Province;Changsha 410006;China
PENG Xiaowei1;2;LI Wei1;TAN Guolin11.Department of OtolaryngologyHead and Neck Surgery;Third Xiangya Hospital of Central South University;Changsha 410013;China;2.Department of Head and Neck Surgery;Tumor Hospital of Hunan Province;Changsha 410006;China
..............page:288-293
Experts consensus on pathological diagnosis of primary liver cancer
Chinese Societies of Liver Cancer and Clinical Oncology;Chinese AntiCancer Association;Liver Cancer Study Group;Chinese Society of Hepatology;Chinese Medical Association;Chinese Pathological Group of Hepatobiliary Tumors and Liver Transplantation CONG Wenming
Chinese Societies of Liver Cancer and Clinical Oncology;Chinese AntiCancer Association;Liver Cancer Study Group;Chinese Society of Hepatology;Chinese Medical Association;Chinese Pathological Group of Hepatobiliary Tumors and Liver Transplantation CONG Wenming
..............page:285-287